Takeda Pharmaceutical Company Limited Stock BOERSE MUENCHEN
Equities
TKDA
US8740602052
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.1 EUR | +0.83% |
|
-1.64% | -6.98% |
06-25 | US CDC alerts healthcare providers of increase in dengue cases | RE |
06-25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
Sales 2024 | 4,264B 26.7B 24.93B 36.46B | Sales 2025 * | 4,285B 26.83B 25.05B 36.63B | Capitalization | 6,552B 41.03B 38.3B 56.02B |
---|---|---|---|---|---|
Net income 2024 | 144B 902M 842M 1.23B | Net income 2025 * | 88.46B 554M 517M 756M | EV / Sales 2024 | 2.57 x |
Net Debt 2024 | 4,386B 27.46B 25.64B 37.5B | Net Debt 2025 * | 4,189B 26.23B 24.49B 35.81B | EV / Sales 2025 * | 2.51 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
75.6
x | Employees | - |
Yield 2024 |
4.49% | Yield 2025 * |
4.67% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 week | -1.64% | ||
Current month | -1.64% | ||
1 month | -0.83% | ||
3 months | -10.45% | ||
6 months | -5.51% | ||
Current year | -6.98% |
![Extreme 11.8](/images/extremecours_fleche.png)
![Extreme 11.8](/images/extremecours_fleche.png)
![Extreme 11.7](/images/extremecours_fleche.png)
![Extreme 11.7](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Date | Price | Change |
---|---|---|
24-06-25 | 12.1 | +0.83% |
24-06-24 | 12 | +1.69% |
24-06-21 | 11.8 | 0.00% |
24-06-20 | 11.8 | -0.84% |
24-06-19 | 11.9 | +0.85% |
Real-time BOERSE MUENCHEN, June 25, 2024 at 03:44 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.19% | 801B | |
+47.26% | 631B | |
-6.09% | 359B | |
+21.92% | 337B | |
+18.40% | 245B | |
+3.64% | 231B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 161B |
- Stock Market
- Equities
- 4502 Stock
- TKDA Stock